Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Equity Average (2020 - 2025)

iSpecimen has reported Equity Average over the past 6 years, most recently at $3.1 million for Q4 2025.

  • Quarterly results put Equity Average at $3.1 million for Q4 2025, down 23.23% from a year ago — trailing twelve months through Dec 2025 was $3.1 million (down 23.23% YoY), and the annual figure for FY2025 was $3.2 million, down 50.97%.
  • Equity Average for Q4 2025 was $3.1 million at iSpecimen, up from $1.8 million in the prior quarter.
  • Over the last five years, Equity Average for ISPC hit a ceiling of $28.7 million in Q1 2022 and a floor of -$29.2 million in Q1 2021.
  • Median Equity Average over the past 5 years was $9.8 million (2023), compared with a mean of $9.3 million.
  • Biggest five-year swings in Equity Average: soared 357.86% in 2022 and later plummeted 82.25% in 2025.
  • iSpecimen's Equity Average stood at $20.9 million in 2021, then grew by 2.03% to $21.4 million in 2022, then plummeted by 47.47% to $11.2 million in 2023, then crashed by 64.25% to $4.0 million in 2024, then dropped by 23.23% to $3.1 million in 2025.
  • The last three reported values for Equity Average were $3.1 million (Q4 2025), $1.8 million (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.